When tapering benzodiazepines, the medication you transition to can make a significant difference in how the taper is managed. For a patient taking a high daily dose of alprazolam (Xanax), a carefully planned transition to a longer-acting benzodiazepine may be considered when clinically appropriate. Why consider a longer-acting option? A longer duration of action can provide more consistent coverage and may help reduce fluctuations between doses during a carefully monitored taper. Another clinical scenario to consider is panic disorder. When starting an SSRI, some patients may experience increased anxiety or activation early in treatment. In certain situations, a benzodiazepine may be used temporarily as a short-term bridge while the SSRI begins to take effect. The key point: Benzodiazepines generally should not become the mainstay of long-term panic disorder treatment. Clinical decisions should be individualized and take into account the patient's medication history, risks of dependence and withdrawal, duration of benzodiazepine use, concurrent medications, and an appropriate tapering strategy. 🧠 For PMHNPs, knowing the pharmacology is only part of the job. Understanding when, why, and how to use these medications safely is where clinical reasoning matters. 💬 When transitioning between benzodiazepines, what factors do you consider first? 🎓 Take Your Psychiatry Training Further If you want to go beyond memorizing medications and build stronger clinical reasoning for real-world psychiatric practice: ⭐ PREMIUM — $199/month or $1,500/year Includes: ✅ All 14 modules ✅ Video lessons and course materials ✅ Downloadable slides and handouts ✅ Comprehensive psychiatry education ✅ Practical concepts to strengthen clinical reasoning and psychiatric decision-making 🔥 VIP — $500/month or $3,500/year Everything in Premium, PLUS: ✅ 1:1 mentorship with Dr. Mena focused on business, branding, and clinical practice ✅ Weekly case discussions ✅ Personalized mentorship and professional guidance